Avian influenza viruses infecting humans

Cellular and Molecular Life Sciences

Volumn 57, Issue 12, 2000, Pages 1770-1784

  Subbarao, K ^a   Katz, J ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Avian influenza; Genetic features; H5N1; Influenza; Pandemic; Pathogenesis

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; VIRUS VACCINE;

EPIDEMIC; FOWL; HONG KONG; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A; INTERMEDIATE HOST; NONHUMAN; REVIEW; VACCINATION; VIRUS CELL INTERACTION; VIRUS GENE; ZOONOSIS;

ANATIDAE; AVES; AVIAN INFLUENZA VIRUS; GALLIFORMES; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0033679749     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000657     Document Type: Review

References (99)

1. Evolution and ecology of influenza A viruses
2. Global epidemiology of influenza: Past and present
3. Avian-tohuman transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics
4. Replication of avian influenza viruses in humans
5. Conjunctivitis in human beings caused by influenza A virus of seals
6. Avian influenza virus isolated from a woman with conjunctivitis
7. A pandemic warning?
8. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness
9. Human infection with influenza H9N2
10. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
11. Comparative study of fowl plague virus and a virus isolated from man
12. Fowl plague virus from man
13. A case report of fowl plague keratoconjunctivitis
14. Case-control study of risk factors for avian influenza A (H5NI) disease, Hong Kong, 1997
15. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
16. Risk of influenza A (H5N1) infection among health-care workers exposed to patients with influenza A (H5N1), Hong Kong
17. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong
18. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong
19. Molecular characterization of H9N2 influenza viruses: Were they the donors of the 'internal' genes of H5N1 viruses in Hong Kong?
20. Discovery of humans infected by avian influenza A (H9N2) virus
21. Virulence of influenza A virus for mouse lung
22. A novel mechanism for the acquisition of virulence by a human influenza A virus
23. Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1 and PB2 genes in virulence
24. A single gene determines the host range of influenza virus
25. Host range mutants of an influenza A virus
26. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range
27. Characterization of a gene coding for M proteins which is involved in host range restriction of an avian influenza A virus in monkeys
28. Characterisation of an avian influenza A virus isolated from a human is an intermediate host necessary for the emergence of pandemic influenza viruses?
29. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes
30. Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus
31. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential
32. An Arg-Lys insertion at the hemagglutinin cleavage site of an H5N2 avian influenza isolate
33. Molecular mechanism of acquisition of virulence in influenza virus in nature
34. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin
35. Host cell proteases controlling virus pathogenicity
36. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin
37. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential
38. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses
39. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens and wild aquatic birds have distinguishable properties
40. The N2 neuraminidase of human imfluenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity
41. Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys
42. A general overview of viral vaccine development
43. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults
44. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1NI) reassortant virus vaccine retains partial virulence for infants and children
45. Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract
46. Characterization of the M protein and nucleoprotein genes of an avian influenza A virus which are involved in host range restriction in monkeys
47. Generation of influenza A viruses entirely from cloned cDNAs
48. Rescue of influenza A virus from recombinant DNA
49. Genetic characterization of the pathogenic influenza A/ Goose/Guangdong/1/96 (H5NI) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong
50. Human influenza A H5NI virus related to a highly pathogenic avian influenza virus
51. Alterations of the stalk of the influenza virus neuraminidase: Deletions and insertions [published erratum appears in Virus Res. [(1993) 29(3): 321]
52. Biologic importance of neuraminidase stalk lenth in influenza A virus
53. Characterization of the surface proteins of influenza A (H5NI) viruses isolated from humans in 1997-1998
54. Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong
55. Avian-to-human transmission of H9N2 subtype influenza A viruses Relationship between H9N2 and H5NI human isolates
56. Replication of avian influenza A viruses in mammals
57. Potential for transmission of avian influenza viruses to pigs
58. Failure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions
59. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays
60. Serological evidence of human infections with avian influenza viruses. Brief report
61. An epidemiological study of influenza viruses among Chinese farm families with household ducks and pigs
62. Influenza infection in humans and pigs in southeastern China
63. Pandemic influenza: A zoonosis?
64. Newcastle disease virus in man
65. Temperature-sensitive mutants of influenza virus III. Further characterizationof the ts-1 [E] influenza A recombinant (H3N2) virus in man
66. Influenza
67. Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins
68. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
69. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo
70. Heterologous protection against influenza by injection of DNA encoding a viral protein
71. Protection against a lethal avian influenza A virus in a mammalian system
72. Induction and activity of class II-restricted, Lyt-2 + cytolytic T lymphocytes specific for the influenza H5 hemagglutinin
73. Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin
74. Human cytotoxic T-lymphocyte repertoire to influenza A viruses
75. Human CD8 + and CD4 + T lymphocyte memory to influenza A viruses of swine and avian species
76. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge
77. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8 + cytotoxic T cells
78. Cytotoxic T-cell immunity to influenza
79. Characterization of an influenza A virus from seals
80. Mass mortality of harbor seals: Pneumonia associated with influenza A virus
81. Are seals frequently infected with avian influenza viruses?
82. The appearance of H3 influenza viruses in seals
83. Characterization of a new avian-like influenza A virus from horses in China
84. Evolution of pig influenza viruses
85. Characterization of influenza A/HongKong/156/ 97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
86. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
87. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong
88. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans
89. Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses
90. Response of ferrets and monkeys to intranasal infection with human, equine and avian influenza viruses
91. Influenza A virus recycling revisited
92. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir
93. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: Potential role of defective interfering RNAs in nature
94. An influenza epicentre?
95. Recombinant influenza A virus vaccines for the pathogenic human A Hong Kong 97 (H5N1) viruses
96. Avirulent avian nfluenza virus as a vaccine strain against a potential human pandemic
97. Vaccines against H5N1 influenza
98. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes
99. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice